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Abstract
Introduction: Dyskeratosis congenita is a rare genodermatosis, characterized by a triad of reticular
skin pigmentation, nail dystrophy and leukoplakia of mucous membranes. It is also associated with a
variety of non-cutaneous abnormalities such as bone marrow failure, malignancy and pulmonary
complications. Among its wide range of clinical manifestations, fatal pneumothorax has rarely been
reported.
Case presentation: We report the case of a 31-year-old Lebanese woman with dyskeratosis
congenita who succumbed to devastating bilateral pneumothoraces.
Conclusion: Careful surveillance of patients with dyskeratosis congenita is required as incipient
respiratory failure due to pneumothorax may be successfully treated if detected at an early stage.
Introduction
Dyskeratosis congenita(DC) isaninherited syndromethat
was first described by Zinsser in 1910, and further
characterized by Engman (1926) and Cole et al. in 1930
[1]. It is estimated to occur in 1 in 1 million people, with
death occurring at a median age of 16 [1]. It typically
presents with a triad of mucocutaneous abnormalities
consisting of reticulated skin hyperpigmentation, nail
dystrophy (both occurring in almost 100% of cases), and
mucosal leukoplakia (80% of cases) [1]. Other features
occur with lower frequencies and involve virtually every
organ system (Table 1) [1–3]. Although rare (approxi-
mately one case per million individuals) [4], DC is a
serious and usually fatal condition. The main causes of
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70%), pulmonary complications (~10–15%), and malig-
nancy (~5–10%) [2].
Pulmonary involvement occurs in as many as 20% of DC
patients [5]. A wide spectrum of respiratory manifestations
has been reported, including asthma, pulmonary fibrosis,
hepatopulmonary syndrome, pulmonary microvasculature
abnormalities, bronchiectasis, fibrocystic dysplasia, Pneu-
mocystis jiroveci pneumonia and chronic pneumonitis [6–9].
In this article, we describe an unusual case of fatal bilateral
spontaneous pneumothoraces in a woman with DC.
Case presentation
A 31-year-old Lebanese woman presented to our medical
centre with acute onset of shortness of breath and pleuritic
chest pain. Her medical history dated back to 20 years
before presentation, when she started developing neck and
upper chest skin hyperpigmentation along with progres-
sive hair loss. A few years later, she was found to have
pancytopenia and bone marrow hypoplasia and was
diagnosed with DC. Since that time, she had been
receiving blood transfusions regularly in another medical
institution. Her family history was remarkable for parental
consanguinity and a diagnosis of DC in one sister who
died of an unknown DC-associated complication. The
review of systems was non-contributory.
Physical examination showed a tall, slender woman with
diffuse alopecia, loss of eyebrows and areas of reticulate
hyperpigmentation over the neck and upper chest. Patches
of leukoplakia were present on the tongue with atrophy of
the glossal papillae. She was dyspneic at rest but
hemodynamically stable. Hyper-resonance, decreased
breath sounds over the left lung and velcro crackles were
noted on lung examination. In addition, there was atrophy
and longitudinal ridging of the nail beds. No digital
clubbing was noted. Cardiovascular, abdominal, and
neurological examinations were normal.
Chest X-ray revealed a large left pneumothorax estimated
at 35% and reticulonodular infiltrates involving both lung
fields (Figure 1). An X-ray done 1 year earlier showed
bilateral peripheral patchy hyperdensities associated with
pulmonary hyperinflation and areas of honeycombing in
the right lower lobe consistent with interstitial fibrosis
(Figure 2).
A chest tube was inserted into the left pleural space and
placed under negative pressure. Five days later, the left
lung had not expanded despite the absence of a
bronchopleural leak. The patient continued to be hemo-
dynamically stable. Her shortness of breath and pain
improved slightly. The decision was then made to remove
the chest tube and discharge the patient home.
Three months later, she presented again with sudden onset
of chest discomfort. An X-ray of the chest at that time
showed a right-sided pneumothorax estimated at 50%,
with persistence of the old left pneumothorax. A chest tube
was inserted in the right pleural space (Figure 3). She was
later intubated and placed on Assist-Control low-tidal
volume mechanical ventilation for worsening hypoxic
respiratory failure. Her initial FiO2 requirement was 80%
for 3 days, and then progressively decreased to 60%. The
Table 1. Clinical abnormalities reported, so far, in association with
dyskeratosis congenita
Organ system Defect or abnormality
Skin Abnormal skin pigmentation
Chronic dermal ulcer
Hyperhidrosis
Nail Nail dystrophy
Oral cavity Extensive dental caries
Dental loss
Leukoplakia
Squamous carcinoma of the mouth
Hair Premature hair
Alopecia
Grey hair
Sparse eyelashes
Lungs Asthma
Pulmonary fibrosis
Hepatopulmonary syndrome
Pulmonary microvascular abnormalities
Bronchiectasis
Fibrocystic dysplasia
Pneumocystis jiroveci pneumonia
Chronic pneumonitis
Gastrointestinal Esophageal stricture
Peptic ulceration
Enteropathy
Liver disease (cirrhosis, portal hypertension)
Gastrointestinal adenocarcinoma
Genitourinary Hypogonadism
Undescended testes
Urethral stricture
Phimosis
Central Nervous System Learning difficulties
Developmental delay
Mental retardation
Ataxia
Cerebellar hypoplasia
Cerebellar malformation
Microcephaly
Peripheral neuropathy
Hematologic Bone marrow failure
Hodgkin’s lymphoma
Skeletal Osteoporosis
Aseptic necrosis
Scoliosis
Short stature
Ophthalmic Epiphora
Chronic keratoconjunctivitis
Gynecologic and Obstetric Intrauterine growth retardation
Vaginal squamous cell carcinoma
Cervical squamous cell carcinoma
ENT Deafness
Laryngeal carcinoma
Nasopharyngeal carcinoma
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5mmHg. Over a 3-week period, although the chest tubes
were in place and no bronchopleural air leakage was
noted, there was no significant improvement in either of
the bilateral pneumothoraces. The PaO2/FiO2 ratio was
constantly rising, reaching around 360 a month into the
ICU admission, when the patient passed away due to
intractable hypoxic respiratory failure. The poor lung
re-expansion was documented bilaterally by serial X-rays,
a n dt h e r ew a sn oe v i d e n c eo fv e n t i l a t o r - a s s o c i a t e d
pneumonia or any additional comorbidity.
Discussion
DC is a multisystem genodermatosis where distinctive
mucocutaneous lesions occur in combination with bone
marrow failure, pulmonary disease and an increased risk
of malignancy [1]. The mode of inheritance is an X-linked
recessive pattern in the majority of cases [10]. DC
continues to stimulate clinical and research interest
because, although rare, it is devastating for the patient
and his/her family [11].
Our patient presented with several typical features of DC:
reticulate pigmentation of the neck and upper chest with
areas of spared skin (confetti spots), dystrophic nails,
diffuse alopecia, together with the characteristic bone
marrow failure and interstitial fibrosis. The course of her
disease was remarkable for the development of sponta-
neous bilateral pneumothoraces leading to intractable
hypoxic respiratory failure and death despite chest tube
insertion, application of negative pressure and use of
mechanical ventilation. The sister’s DC diagnosis and the
parental consanguinity suggest an autosomal recessive
rather than the more usual X-linked inheritance mode
[10]. Subsequently, three other members of the same
family were diagnosed with DC, making autosomal
recessive inheritance even more likely. Unfortunately,
genetic testing was not available at that time to confirm
the specific genotype or inheritance mode.
Figure 1.
Chest X-ray film taken on the first admission to our institution
showing large left pneumothorax estimated at 35% and
reticulonodular infiltrates involving both lung fields.
Figure 2.
Chest X-ray film taken 1 year before the patient’s first
admission to our institution, showing patchy areas of
increased density in the periphery of both lung fields,
hyperinflation of the lungs and areas of honeycombing in the
right lower lobe consistent with interstitial fibrosis.
Figure 3.
Chest X-ray film taken 3 months after the patient’s first
admission to our institution, showing a right-sided
pneumothorax, estimated at 50%, with persistence of the left
pneumothorax; right chest tube in place.
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reported and poorly documented [7]. However, pulmon-
ary involvement may be underestimated because many
DC patients die at an early age, before the onset of
respiratory symptoms. In addition, DC patients may
present with primary respiratory complaints and the
condition goes unrecognized because of minor dermato-
logic manifestations [10].
A 1973 review of the literature identified fibrotic lung
changes in only 2 of 35 reported patients [12]. The DC
registryestablishedattheHammersmithHospital(London)
reported in year 2000 that 20.3% of 148 patients from 92
families exhibited reduced diffusion capacity and/or restric-
tive defectsonpulmonaryfunctiontesting[2].Sofar,atotal
of eight patients have been reported with biopsy-proven
pulmonary fibrosis [13]. Other reported pulmonary man-
ifestations of DC include asthma, hepatopulmonary syn-
drome, pulmonary microvasculature abnormalities,
bronchiectasis, fibrocystic dysplasia, Pneumocystis jiroveci
pneumonia and chronic pneumonitis [6–9].
Secondary spontaneous pneumothorax is a condition
mainly seen in patients with asthma, chronic obstructive
pulmonary disease (COPD), infections (including abscess,
tuberculosis, Pneumocystis jiroveci pneumonia) and malig-
nancies. It is less commonly reported in patients with
interstitial lung disease as part of specific syndromes such
as lymphangioleiomyomatosis and histiocytosis X. It has
rarely been reported in patients with DC. To the best of our
knowledge, the only report of a pneumothorax complicat-
ing DC was that by Verra et al., in 1992 [7]. The patient in
question was admitted for acute respiratory failure
precipitated by a unilateral, left-sided pneumothorax and
passed away 10 days later despite chest tube insertion and
oxygen therapy. Similarly, our patient developed fatal
bilateral pneumothoraces refractory to chest tube inser-
tion, application of negative pressure and use of mechan-
ical ventilation. In both cases, a pneumothorax occurring
in the setting of DC was fatal.
The pathophysiology of the different DC manifestations
remains incompletely characterized despite significant
advances in our understanding of the genetics and biology
of this disease during the last decade [1]. It is currently
believed that DC arises principally from defective telomere
maintenance, resulting in chromosomal shortening and
gene loss during cell replication ultimately leading to cell
apoptosis, particularly in highly proliferative tissues such
as the hematologic and dermatologic systems [11]. Utz et
al. speculated that pulmonary fibrosis in this setting is
secondary to an abnormal fibroblast function [13]. Once
established, this pulmonary fibrosis may lead to alveolar
wall degeneration, cyst formation and rupture, and there-
fore to a pneumothorax. Furthermore, since DC has been
shown to be associated with pulmonary microvascular
abnormalities [7], it is also possible that pneumothoraces
are the result of pulmonary infarctions. The absence of
lung re-expansion after chest tube insertion observed in
the course of our patient’s illness can be multifactorial: for
example, extensive fibrosis could have permanently
deformed the lung and prevented significant re-expansion,
or infarction involving a significant part of the lung
parenchyma could have delayed healing.
Traditionally, treatment options for bone marrow failure
inpatientswithDCincludeanabolicsteroids(forexample,
oxymetholone), granulocyte macrophage colony-stimulat-
ing factor, granulocyte colony-stimulating factor and
erythropoietin [14]. However, this kind of therapy has
been associated with only a transient increase in blood
counts and serious adverse effects [15]. Hematopoietic
stem cell transplantation has a limited success rate because
of a high prevalence of fatal pulmonary complications,
mainly in patients with significant pre-existing pulmonary
involvement. No data are available, thus far, regarding the
management of pulmonary manifestations in DC patients.
The emerging insights into the molecular biology of this
disease will hopefully provide new opportunities for
preventive and therapeutic interventions.
Conclusion
In summary, we describe the case of a patient with typical
DC symptoms who presented with bilateral pneu-
mothoraces, refractory to existing medical treatment.
This is the second reported pneumothorax occurrence in
the context of DC. In both reports, the outcome was fatal
despite maximal medical therapy. Therefore, a high degree
of suspicion of this and other potential pulmonary
complications in patients with DC, and surveillance
pulmonary function testing and chest imaging are
warranted for early effective interventional strategies.
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